Freeline Announces June 2022 Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Plugin JSON Content Importer Pro not running: Check Licence! Check that a Licence is active for https://freeline.life
You might also like
Freeline Reports Updated Data From Phase 1/2 B-AMAZE Trial in Hemophilia B
Freeline Presents Positive New Data from Phase 1/2 GALILEO-1 Trial of FLT201, Its Novel Gene Therapy Candidate, in Gaucher Disease at ESGCT 30th Annual Congress
Freeline Announces Executive Leadership Changes
Freeline Reports New Data from Fabry Disease Program, Pipeline and Company Updates, Including Appointment of Pamela Foulds, MD as Chief Medical Officer, and Third Quarter 2021 Financial Results
Freeline Reports January 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Freeline Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Get in touch

+44 (0)1438 906870
contact@freeline.life

Follow us on our social channels